Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Neurocrit Care. 2012 Dec;17(3):361–366. doi: 10.1007/s12028-012-9776-z

Table 5.

Secondary analysis: subjects surviving >5 days from ICH onset

Variable All ICH
Lobar ICH
Deep ICH
OR 95 % CI p value OR 95 % CI p value OR 95 % CI p value
AED treatment 1.12 0.69 1.81 0.65 1.39 0.46 4.20 0.56 1.67 0.82 3.40 0.16
Age 1.03 1.01 1.05 0.005 1.03 1.00 1.07 0.08 1.04 1.01 1.07 0.01
Sex 1.37 0.87 2.16 0.18 0.82 0.37 1.81 0.61 1.99 0.99 4.02 0.05
Length of hospital stay 1.01 0.99 1.02 0.44 1.02 0.98 1.07 0.26 1.00 0.98 1.02 0.89
Baseline ICH volume (mL) 1.03 1.02 1.04 <.0001 1.04 1.02 1.05 <.0001 1.04 1.03 1.06 <.0001
Hypercholesterolemia 0.85 0.53 1.36 0.49 0.67 0.28 1.59 0.36 1.06 0.53 2.13 0.87
Hypertension 1.33 0.76 2.32 0.32 0.78 0.33 1.88 0.59 1.13 0.42 3.02 0.82
Atrial fibrillation 0.74 0.37 1.49 0.40 2.65 0.93 7.59 0.07 0.36 0.11 1.17 0.09
Intraventricular 1.99 1.25 3.16 0.004 0.88 0.37 2.10 0.78 1.89 0.92 3.86 0.08
Warfarin 1.56 0.78 3.12 0.21 0.47 0.13 1.73 0.25 3.42 1.21 9.70 0.02